Latest Biologic Stories

2015-02-16 04:21:48

-- Major European markets can finally benefit from the availability of Inflectra following the patent expiry of reference product Remicade® (infliximab) LAKE FOREST, Ill., Feb.

2015-02-13 08:27:51

SAN DIEGO, Feb. 13, 2015 /PRNewswire/ -- Pfenex Inc.

2015-02-12 12:27:45

MUMBAI, February 12, 2015 /PRNewswire/ -- Date Info: 10 Mar 2015 to 11 Mar 2015 Venue Info: The Kensington Close Hotel, Wrights Lane, London, UK

2015-02-11 08:32:46

LONDON, February 11, 2015 /PRNewswire/ -- Report Details Biosimilar therapeutic antibodies - see why originator companies should now fear those competitors,

2015-02-10 16:26:35

Provides additional details on AT-001 pivotal efficacy study, announces two technical section complete letters for safety, provides manufacturing update for AT-004, and announces completion of enrollment

2015-02-10 08:34:14

SAN DIEGO and LAKE FOREST, Ill., Feb. 10, 2015 /PRNewswire/ -- Pfenex Inc.

2015-02-05 23:04:53

BCC Research (http://www.bccresearch.com) reveals in its new report on biologic therapeutic drugs; the biologics or biopharmaceutical therapeutic

2015-02-03 08:31:55

-- CEO to Participate on "Trust Your Gut" - Therapeutic Opportunities from the Microbiome Panel -- ROCKVILLE, Md., Feb. 3, 2015 /PRNewswire/ -- Synthetic Biologics, Inc.

Word of the Day
  • A serpent whose bite was fabled to produce intense thirst.
The word 'dipsas' comes from a Greek word meaning 'thirst'.